BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 26323892)

  • 21. Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine.
    Yang J; Fang Z; Wu J; Yin X; Fang Y; Zhao F; Zhu S; Li Y
    Tumour Biol; 2016 Oct; 37(10):13871-13883. PubMed ID: 27485114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lumiflavin increases the sensitivity of ovarian cancer stem-like cells to cisplatin by interfering with riboflavin.
    Yang R; Wei Z; Wu S
    J Cell Mol Med; 2019 Aug; 23(8):5329-5339. PubMed ID: 31187586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ursolic Acid Inhibits Tumor Growth via Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cells.
    Wang X; Wang T; Yi F; Duan C; Wang Q; He N; Zhu L; Li Q; Deng W
    Biol Pharm Bull; 2019; 42(5):685-691. PubMed ID: 31061311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of down-regulated transcriptional repressor ZEB1 on the epithelial-mesenchymal transition of ovarian cancer cells.
    Chen D; Wang J; Zhang Y; Chen J; Yang C; Cao W; Zhang H; Liu Y; Dou J
    Int J Gynecol Cancer; 2013 Oct; 23(8):1357-66. PubMed ID: 24257549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer.
    Liu N; Peng SM; Zhan GX; Yu J; Wu WM; Gao H; Li XF; Guo XQ
    Oncol Rep; 2017 Sep; 38(3):1464-1472. PubMed ID: 28713970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin.
    Quan MF; Xiao LH; Liu ZH; Guo H; Ren KQ; Liu F; Cao JG; Deng XY
    World J Gastroenterol; 2013; 19(43):7680-95. PubMed ID: 24431896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low concentration of quercetin antagonizes the cytotoxic effects of anti-neoplastic drugs in ovarian cancer.
    Li N; Sun C; Zhou B; Xing H; Ma D; Chen G; Weng D
    PLoS One; 2014; 9(7):e100314. PubMed ID: 24999622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Observation of ovarian cancer stem cell behavior and investigation of potential mechanisms of drug resistance in three-dimensional cell culture.
    Chen J; Wang J; Zhang Y; Chen D; Yang C; Kai C; Wang X; Shi F; Dou J
    J Biosci Bioeng; 2014 Aug; 118(2):214-22. PubMed ID: 24684961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile.
    Latifi A; Abubaker K; Castrechini N; Ward AC; Liongue C; Dobill F; Kumar J; Thompson EW; Quinn MA; Findlay JK; Ahmed N
    J Cell Biochem; 2011 Oct; 112(10):2850-64. PubMed ID: 21618587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
    Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
    BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120).
    Huang RY; Kuay KT; Tan TZ; Asad M; Tang HM; Ng AH; Ye J; Chung VY; Thiery JP
    Oncotarget; 2015 Sep; 6(26):22098-113. PubMed ID: 26061747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ursolic acid inhibits the proliferation of triple‑negative breast cancer stem‑like cells through NRF2‑mediated ferroptosis.
    Yang X; Liang B; Zhang L; Zhang M; Ma M; Qing L; Yang H; Huang G; Zhao J
    Oncol Rep; 2024 Jul; 52(1):. PubMed ID: 38847277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The inhibitory effect of doxycycline on cisplatin-sensitive and -resistant epithelial ovarian cancer.
    Wu W; Yu LH; Ma B; Xu MJ
    PLoS One; 2014; 9(3):e89841. PubMed ID: 24598933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Establishment and biological characteristics of a platinum-resistance nude mouse model in epithelial ovarian cancer].
    Shi L; Yu H; Zhang W; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):523-30. PubMed ID: 25327735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation.
    Liu L; Salnikov AV; Bauer N; Aleksandrowicz E; Labsch S; Nwaeburu C; Mattern J; Gladkich J; Schemmer P; Werner J; Herr I
    Int J Cancer; 2014 May; 134(10):2489-503. PubMed ID: 24615157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory action of pristimerin on hypoxia‑mediated metastasis involves stem cell characteristics and EMT in PC-3 prostate cancer cells.
    Zuo J; Guo Y; Peng X; Tang Y; Zhang X; He P; Li S; Wa Q; Li J; Huang S; Xu D
    Oncol Rep; 2015 Mar; 33(3):1388-94. PubMed ID: 25571882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silencing stem cell factor attenuates stemness and inhibits migration of cancer stem cells derived from Lewis lung carcinoma cells.
    Wang L; Wang J; Li Z; Liu Y; Jiang M; Li Y; Cao D; Zhao M; Wang F; Luo F
    Tumour Biol; 2016 Jun; 37(6):7213-27. PubMed ID: 26666817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer.
    Zhang Y; Wang Z; Yu J; Shi Jz; Wang C; Fu Wh; Chen Zw; Yang J
    Cancer Lett; 2012 Sep; 322(1):70-7. PubMed ID: 22343321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inter-regulation of IGFBP1 and FOXO3a unveils novel mechanism in ursolic acid-inhibited growth of hepatocellular carcinoma cells.
    Yang LJ; Tang Q; Wu J; Chen Y; Zheng F; Dai Z; Hann SS
    J Exp Clin Cancer Res; 2016 Mar; 35():59. PubMed ID: 27036874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.